arrow
M

Michael C. Jensen

Seattle Children's Research Institute
H指数:80
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome-wide CRISPRa screens identify modulators of CAR T survival across diverse tumor cytokine milieus

全基因组CRISPRa筛选鉴定了在多样化肿瘤细胞因子微环境中调节CAR T细胞存活的调控因子

2026-09-280
OAAI
Intracerebroventricular B7-H3-targeting chimeric antigen receptor T cells for non-pontine diffuse midline glioma and recurrent/refractory pediatric CNS tumors: A phase 1 trial

脑室内B7-H3靶向嵌合抗原受体T细胞治疗非脑桥弥漫性中线胶质瘤和复发/难治性儿童中枢神经系统肿瘤:一项1期临床试验

2026-07-250
PRE
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma

组合B7-H3 CAR T细胞与ONC206对弥漫性内生性脑桥胶质瘤的疗效研究

2026-03-011
PRE
Engineered CXCR3-A expression enhances B7-H3-targeting CAR T cell migration and efficacy against diffuse intrinsic pontine glioma

工程化CXCR3-A表达增强B7-H3靶向CAR T细胞的迁移和对弥漫性内生性脑桥胶质瘤的疗效

2025-11-110
OAAI
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04

开创性四靶点CAR T细胞疗法在儿童中枢神经系统肿瘤中的应用——来自第一项人体I期临床试验BRAINCHILD-04的分析

2025-11-010
OAAI
Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03

儿童弥漫性内生性脑桥胶质瘤患者在接受B7-H3靶向CAR T细胞治疗(BrainChild-03)时出现的肿瘤炎症相关神经毒性

2025-09-011
PRE
Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trial

Gust J,Cole BL,Ronsley R,Wilson AL,Seidel K,Wendler J,等. 局部区域灌注EGFR806-CAR T细胞治疗复发或难治性儿童中枢神经系统肿瘤:已完成brainChild02期1临床试验的结果. Neuro Oncol. (2025). doi: 10.1093/neuonc/noaf064

2025-06-016
PRE
Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia

外周血计数低和升高的促炎细胞因子预示急性淋巴细胞白血病中CD19嵌合抗原受体T细胞反应不良

2025-05-200
OAAI
Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL

PLAT-02和PLAT-03的研究结果:评估CD19 CAR T细胞疗法及CD19表达T-APC支持在儿童B-ALL中的应用

Blood
IF23.1
2025-04-170
PRE
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04
2024-11-110
PRE
INTRAVENTRICULAR B7-H3 CAR T CELLS FOR DIFFUSE INTRINSIC PONTINE GLIOMA: SAFETY AND EFFICACY REPORT FROM THE COMPLETED PHASE 1 TRIAL BRAINCHILD-03

脑室内B7-H3 CAR T细胞治疗弥漫性内在性脑桥胶质瘤: 已完成的1期试验BRAINCHILD-03的安全性和有效性报告

2024-06-181
OAAI
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04
2024-06-181
OAAI
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing

药物调节的CD33-targeted CAR T细胞使用临床优化的雷帕霉素剂量控制AML

2024-03-198
OAAI